Disc Medicine, Inc.
IRON
$70.03
$1.502.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 93.88% | 112.71% | 112.48% | 104.85% | 57.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 74.04% | 91.37% | 106.04% | 99.05% | 26.97% |
| Operating Income | -74.04% | -91.37% | -106.04% | -99.05% | -26.97% |
| Income Before Tax | -86.81% | -106.42% | -134.92% | -109.93% | -26.06% |
| Income Tax Expenses | -57.14% | -50.00% | -10.53% | -13.33% | 2,280.00% |
| Earnings from Continuing Operations | -86.31% | -105.49% | -134.30% | -109.65% | -26.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.31% | -105.49% | -134.30% | -109.65% | -26.48% |
| EBIT | -74.04% | -91.37% | -106.04% | -99.05% | -26.97% |
| EBITDA | -73.91% | -91.16% | -105.84% | -99.48% | -27.01% |
| EPS Basic | -61.30% | -63.77% | -99.39% | -53.53% | 5.84% |
| Normalized Basic EPS | -61.74% | -62.20% | -99.89% | -53.72% | 6.16% |
| EPS Diluted | -61.30% | -63.77% | -99.39% | -53.53% | 5.84% |
| Normalized Diluted EPS | -61.74% | -62.20% | -99.89% | -53.72% | 6.16% |
| Average Basic Shares Outstanding | 15.50% | 25.47% | 17.51% | 36.55% | 34.32% |
| Average Diluted Shares Outstanding | 15.50% | 25.47% | 17.51% | 36.55% | 34.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |